BioSphere Medical Embosphere

Bioengineered microspheres gain 510(k) clearance for the minimally invasive treatment of vascular malformations and tumors via embolization. Embosphere will be directly marketed by a team of reps supported by a clinical team. BioSphere launched Phase I trials of the device in uterine artery embolization for uterine fibroid treatment in January